The data illustrates the top 10 therapeutic classes by global pharmaceutical sales in 2017. In that year, the global pharmaceutical industry is estimated to generate a total revenue of some 36 billion USD through mental health drug spending.
Top therapeutic classes and drugs
Oncologics, pain therapy, and anti-diabetics are among the top global pharmaceuticals based on revenues, generating 81 billion USD, 76 billion USD, and 72 billion USD, respectively, in 2017. In oncologic developments, drugs for non-small cell lung cancer and breast cancer were among the leading diseases in therapeutic drug development.
